Daiichi Sankyo Company, Limited (TYO:4568)
2,633.00
+32.00 (1.23%)
Oct 15, 2026, 12:55 PM JST
Daiichi Sankyo Company Employees
Daiichi Sankyo Company had 20,171 employees as of March 31, 2026. The number of employees increased by 406 or 2.05% compared to the previous year. That makes Daiichi Sankyo Company the 1,815th largest employer in the world and 174th in Japan.
Employees
20,171
Change (1Y)
406
Growth (1Y)
2.05%
Revenue / Employee
110.22M JPY
Profits / Employee
13.03M JPY
Market Cap
4.79T
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 20,171 | 406 | 2.05% |
| Mar 31, 2025 | 19,765 | 1,039 | 5.55% |
| Mar 31, 2024 | 18,726 | 1,291 | 7.40% |
| Mar 31, 2023 | 17,435 | 977 | 5.94% |
| Mar 31, 2022 | 16,458 | 425 | 2.65% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Takeda Pharmaceutical Company | 47,029 |
| Otsuka Holdings | 37,758 |
| HOYA Corporation | 37,752 |
| Olympus | 28,138 |
| M3, Inc. | 17,010 |
| Astellas Pharma | 14,099 |
| Eisai | 10,543 |
| Shionogi & | 6,223 |
Daiichi Sankyo Company News
- 12 days ago - Daiichi Sankyo, AstraZeneca, Summit Partner On Datroway- Ivonescimab Cancer Studies - Nasdaq
- 12 days ago - Daiichi Sankyo, AstraZenca, Summit Partner To Evaluate Datroway Plus Ivonescimab - Nasdaq
- 12 days ago - AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combination - Reuters
- 15 days ago - Daiichi Sankyo Co Ltd's Dividend Analysis - GuruFocus
- 16 days ago - Daiichi, Merck Withdraw U.S. Filing For Lung Cancer Drug Ifinatamab Deruxteca - Nasdaq
- 19 days ago - Daiichi Sankyo and Merck Withdraw Ifinatamab Deruxtecan BLA; MRK Stock Reacts - GuruFocus
- 19 days ago - Merck, Daiichi Sankyo withdraw US application for lung cancer drug - Reuters
- 20 days ago - Malaysia's IHH's unit appeals Tokyo court's rejection of Daiichi Sankyo damages claim - Reuters